MFS Active Core Plus Bond ETF (MFSB) 시세

Why do you choose to bother me with such silliness, P3 results are out if you have not been notified. Please look to make your living in a better profession as I am sure you have marketable skills somewhere. Thx

GLTA

$SHPH Article Strong Data from NIH Sponsored Clinical Trial Suggests Ropidoxuridine Could be Major Advancement for Cancer Patients and Big Win for Shuttle Pharmaceuticals’ Shareholders
https://richardacavalli.wixsite.com/greenplanetmicrocaps/windfall-cancer-treatment

Let's see how low BIEL goes today.😎

UPB in da HIZZLE

TTD
Trade Desk remains best idea, attractive opportunity still ahead, says Baird
Baird analyst Vikram Kesavabhotla reiterates Trade Desk as a best idea, telling investors in a research note that the firm remains constructive and believes there is an attractive opportunity still ahea

RCAT NEWS with PLTR https://finviz.com/quote.ashx?t=RCAT

and ER coming up

GM FOLKSSS

$YOU Buy rating w/ $45 PT reiterated at Needham

Mars bars are about a Buck Fifty.

$SHPH Article Strong Data from NIH Sponsored Clinical Trial Suggests Ropidoxuridine Could be Major Advancement for Cancer Patients and Big Win for Shuttle Pharmaceuticals’ Shareholders
https://richardacavalli.wixsite.com/greenplanetmicrocaps/windfall-cancer-treatment

Investment , I imagine you don’t have to worry about buying too many Christmas presents do you?
Something tells me you don't have many friends. That is why you post so much on this board. You love it when people respond to your post. You really TRY hard to get a response.
Ser

This is A must Watch‼️

https://share.icloud.com/photos/0ceTWF8YKRPf7CPD2-AgnRkjw

There are various scenarios possible, such as the shorters on the forum who portray the company as a major fraud, and then the longs who overpromote the company. But if the truth lies somewhere in between, I believe you need to piece the puzzle together yourself. With a CEO like LeMaitre and Connell

You can take Oxy off your fantasy "catalyst"
what if list...now what ??

As far as my wife is concerned, the share price is $0.000001. I know it will be $0.001 in a couple weeks, but she is much less convinced. Also, with the "D" designation, we common shareholders won't be able to trade for about 30 days until the "D" comes off. The share price will fluctuate wildly

Kund
I am the worst guy to talk about these things and you are more informed than I am, but just to get the top line is progress...ha ha
I don't disagree with you that Missling's secretive ways of dealing with scientific medical protocols, shareholders, etc are a big problem., but thi

Nice picture. People in the textile industry need to start buying.

So many excuses ….. now we have a retired broker who seems to also know the fate of LWLG (how old is this guy ?? 85 ?? Does he have a @aol.com email addesss so I can connect with him ? Love to learn more about LWLG.

Tom Zelibor is a total loser. He’s also the loser in that other deal

Lionsgate has never verified and/or confirmed the "deal." with SAPX.

There isn't even a quote from anybody from Lionsgate confirming the deal in the press release like all press releases have when confirming a deal between two companies.

The Lionsgate deal also doesn't

Velocity. Russian Anti-StarLink. 4 minutes https://youtu.be/_ZR_bxk1E1A?si=mnv3iRUfeaFup2wR

https://finance.yahoo.com/m/a00aaa55-9c87-333d-a96e-9374e0fea86c/palantir-microstrategy-axon.html

@karlacorn3 if you read between the lines, it makes a lot of sense, especially when you consider my response to it. Combine his reply with RD’s earlier comments on that other board (particularly the one where he states this board has no further use), and you’ll start to see what's at play.

Your pre-split cost is about $0.003356, now $8.39. My pre-split cost was $0.00064, so now mine is $1.60